Evolent Health, Inc EVH
3.61
0.09
2.56%
as of 25 Sep
- Market cap
- $398.0M
- P/E
- 0.0×
Follow EVH
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (79.90%) | (80.15%) | (81.81%) | (19.23%) |
+8 more TTM periods Free account |
|
| (23.05%) | (23.55%) | (26.08%) | (7.30%) | ||
ROIC |
(22.06%) | (21.76%) | (21.22%) | (0.73%) | |
Return on Tangible Assets |
(256.04%) | (264.31%) | (286.98%) | (82.13%) | |
Average Days of Receivables |
78.17 | 60.71 | 60.28 | 68.69 | |
Free Cash Flow per Share |
0.22 | 0.01 | 0.04 | (0.60) | |
Free Cash Flow |
24.34 | 1.40 | 4.76 | (68.67) | |
Capital Expenditures |
(29.98) | (31.90) | (34.09) | (32.48) | |
Piotroski F-Score |
5.00 | 4.00 | 4.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
3.65% | 2.17% | 2.48% | (1.78%) | |
Accounts Receivable Turnover |
5.19 | 5.07 | 5.18 | 5.17 | |
Accounts Payable Turnover |
32.05 | 24.96 | 18.95 | 27.41 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
8.17 | 15.25 | 14.78 | 15.72 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.01 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
13.92% | 15.79% | 16.20% | 13.58% | |
Share Based Compensation of Revenue |
2.05% | 2.08% | 2.12% | 1.52% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(0.11) | (0.06) | (0.07) | 0.20 | |
Depreciation/Fixed assets |
6.44 | 6.50 | 6.54 | 1.41 | |
Capex/Depreciation |
(0.06) | (0.06) | (0.06) | (0.29) | |
Revenue per Share |
18.63 | 16.88 | 16.43 | 18.01 | |
Operating CF per Share |
0.48 | 0.30 | 0.34 | (0.32) | |
Capex per Share |
(0.27) | (0.29) | (0.30) | (0.28) | |
Capex to Sales |
0.01 | 0.02 | 0.02 | 0.02 | |
Net Profit Margin |
(24.37%) | (28.26%) | (30.88%) | (8.81%) |
Columns are period end dates